Wells Fargo Initiates Coverage On ALX Oncology Holdings with Overweight Rating, Announces Price Target of $5

Benzinga Newsdesk www.benzinga.com Neutral 71.3%

Neg 0% Neu 71.3% Pos 0%

Wells Fargo analyst Derek Archila initiates coverage on ALX Oncology Holdings (NASDAQ:ALXO) with a Overweight rating and announces Price Target of $5.